38 results
8-K
EX-99.1
PRCT
Procept BioRobotics Corp
3 May 24
Regulation FD Disclosure
8:57am
BioRobotics Corporation. All Rights Reserved. COMMERCIAL STRATEGY SHAM SHIBLAQ Chief Commercial Officer
13 BPH Market Remains Underpenetrated 354 2,700 … Reserved
44 Active Surveillance & Focal Therapy Both Aim to Delay or Avoid Radical Treatment and Its Respective Morbidities Strategy Cost to Patient
8-K
EX-9.01
PRCT
Procept BioRobotics Corp
1 May 24
Results of Operations and Financial Condition
7:23am
, commercial momentum, reimbursement coverage, overall business strategy, or information regarding the impact of other global events on the Company
8-K
EX-9.01
9y0xg
27 Feb 24
Results of Operations and Financial Condition
4:07pm
8-K
EX-99.1
jrjjo1tk6y0lt1eg8
1 Nov 23
PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
4:10pm
424B5
4fnw kg3ei6
3 Aug 23
Prospectus supplement for primary offering
4:01pm
424B5
qqou6y
1 Aug 23
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
u4q2are2d2 84
27 Jul 23
PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
7:09am
8-K
EX-99.1
waz xdu99m
28 Apr 23
Regulation FD Disclosure
8:30am
8-K
EX-99.1
q6o94pzu13
27 Apr 23
PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
7:02am
8-K
EX-99.1
hqrf7gw 26xlv9uvu
3 Nov 22
PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
4:10pm
8-K
EX-99.1
rbf8ujc7bf keuaj
4 Aug 22
PROCEPT BioRobotics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
5:22pm